DECK vs VRTX · P/E 16, rev $4.99B vs P/E 30, rev $12.00B
Deckers Outdoor Corporation (DECK) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Deckers Outdoor Corporation (DECK) is a footwear & accessories company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported DECK revenue for 2025-03-31 was $4.99B. Net income was $966.1M. Revenue was up 419.5% from 2024-03-31 to 2025-03-31. DECK currently screens at market cap $15.23B and trailing P/E 16.1.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
DECK currently screens at market cap $15.23B and trailing P/E 16.1. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the DECK and VRTX stock pages for the full models.
Not investment advice.